PedAM
Pediatric Disease Annotations & Medicines
| Disease | liver disease |
| Symptom | |hepatitis c |
| Sentences | 69 |
| PubMedID- 24695489 | End stage liver disease associated with hepatitis c virus infection constitutes one of the principal indications for liver transplant. |
| PubMedID- 22087124 | Background: nonalcoholic fatty liver disease develops in patients with chronic hepatitis c. |
| PubMedID- 21645344 | In this article we discuss several liver conditions which are directly affected by overweight and obese status, including non-alcoholic fatty liver disease, chronic infection with hepatitis c virus and post-liver transplant status. |
| PubMedID- 22419479 | We enrolled 184 hepatitis c-infected patients with chronic liver diseases or hcc, 57 healthy subjects and 27 hcc patients with other etiology. |
| PubMedID- 25848478 | However, chronic hepatitis c is associated with a higher liver disease related cardiovascular and all-cause mortality of hd patients. |
| PubMedID- 21918437 | Management of end-stage liver disease in hiv/hepatitis c virus co-infection. |
| PubMedID- 22797645 | Effect of silymarin (milk thistle) on liver disease in patients with chronic hepatitis c unsuccessfully treated with interferon therapy: a randomized controlled trial. |
| PubMedID- 24575168 | Conclusion: genetic mutations that cause inherited liver diseases in patients with hepatitis c should be studied in detail. |
| PubMedID- 21188525 | Dietary history and physical activity and risk of advanced liver disease in veterans with chronic hepatitis c infection. |
| PubMedID- 20386865 | The mechanisms by which alcohol consumption accelerates liver disease in patients with chronic hepatitis c virus (hcv) are not well understood. |
| PubMedID- 26182389 | Chronic hepatitis c is one of the liver diseases that show hepatic iron accumulation. |
| PubMedID- 21258658 | Hepatitis b and hepatitis c are important causes of chronic liver disease globally. |
| PubMedID- 22359532 | Nested case control studies have a distinct advantage from traditional case control studies because both cases and controls are chosen from the same, well-defined source population, in this study from the halt-c study population where all patients had chronic hepatitis c infection with chronic liver disease. |
| PubMedID- 23226395 | liver diseases resulting from hepatitis c virus (hcv) infection is a major health issue worldwide as well as the united states . |
| PubMedID- 22163170 | The most common indication for lt was end-stage liver disease attributed to hepatitis c infection. |
| PubMedID- 25088088 | Background and aim: assessment of the severity of liver disease following infection with hepatitis c virus (hcv) is important in treatment selection and prognosis. |
| PubMedID- 24251712 | Chronic hepatitis c is one of the liver diseases that show hepatic iron accumulation, even though its level should be recognized to be basically mild to moderate and sometimes within the normal range. |
| PubMedID- 26503379 | Moderate sustained virologic response rates with 6-week combination directly acting anti-hepatitis c virus therapy in patients with advanced liver disease. |
| PubMedID- 19800334 | Background & aims: human immunodeficiency virus (hiv) infection accelerates liver disease progression in patients with hepatitis c virus (hcv) and could shorten survival of those awaiting liver transplants. |
| PubMedID- 21331379 | Tlr-mediated signals result in liver disease associated with hepatitis b, hepatitis c, alcoholicnonalcoholic steatohepatitis, and hepatic fibrosis . |
| PubMedID- 20616580 | Lipid metabolism and liver disease in hepatitis c viral infection. |
| PubMedID- 23630437 | Status of essential trace minerals and oxidative stress in viral hepatitis c patients with nonalcoholic fatty liver disease. |
| PubMedID- 21849046 | In one of the studies, mmp-9 levels were negatively correlated to the histological severity of the liver disease in patients with chronic hepatitis c . |
| PubMedID- 22030902 | Risk for future clinical outcomes is proportional to the severity of liver disease in patients with chronic hepatitis c virus (hcv). |
| PubMedID- 21145859 | Role of a cirrhosis risk score for the early prediction of fibrosis progression in hepatitis c patients with minimal liver disease. |
| PubMedID- 25288416 | We found nationwide trends in increasing morbidity and medical costs for advanced liver disease associated with hepatitis c. |
| PubMedID- 23869664 | Progression of liver disease is common with hepatitis c virus (hcv) infection and known to be accelerated in the presence of hiv 4,5. according to current guidelines, all coinfected patients with chronic hcv infection and significant fibrosis (≥f2) should be considered for hcv therapy given their increased risk of death from liver disease 6,7. hcv treatment should preferentially be offered to patients with controlled hiv infection, and therefore it is recommended when cd4 cell counts are above 350 cells/μl and often deferred when counts are below 200 cells/μl 7. however, patients with cd4 cell counts below 200 cells/μl have been shown to respond well to hcv treatment when hiv replication is suppressed 8. despite these recommendations, the extent to which hiv/hcv-coinfected patients start hcv therapy is not well documented in europe. |
| PubMedID- 23707779 | Dietary cholesterol intake is associated with progression of liver disease in patients with chronic hepatitis c: analysis of the hepatitis c antiviral long-term treatment against cirrhosis trial. |
| PubMedID- 19902246 | Antiviral therapy of chronic hepatitis c in patients with advanced liver disease and after liver transplantation. |
| PubMedID- 23703797 | Vitamin d is an important immune modulator that plays an emerging role in inflammatory and metabolic liver diseases, including infection with hepatitis c virus (hcv). |
| PubMedID- 26138651 | Background: rising rates of obesity, diabetes mellitus (dm), and nonalcoholic fatty liver disease among patients with chronic hepatitis c virus infection (hcv) may contribute to more rapid disease progression. |
| PubMedID- 21057160 | Twenty-one patients (62%) had liver disease associated with hepatitis c virus (hcv) and 5 patients with hepatitis b virus (62%). |
| PubMedID- 25030555 | Association between gene polymorphisms of connective tissue growth factor and the progression of chronic liver disease associated with hepatitis c. |
| PubMedID- 25716364 | Functional and morphological myocardial changes in hepatitis c virus patients with end-stage liver disease. |
| PubMedID- 21029257 | Uptake of hepatitis c antibody testing in patients with end-stage liver disease in glasgow, 1993-2007. |
| PubMedID- 25457210 | Background & aims: genetic variants of patatin-like phospholipase domain-containing 3 (pnpla3) and diabetes are associated with liver disease severity, in patients with chronic hepatitis c (chc) infection. |
| PubMedID- 24130726 | This study analyses the evolution of liver disease in women with chronic hepatitis c during the third trimester of pregnancy and the post-partum period, as a natural model of immune modulation and reconstitution. |
| PubMedID- 24723944 | Had underling liver disease with mostly hepatitis c virus (hcv) serologically positive (123/271, 45.4%) but not with hbv (78/271, 28.8%); however, the patients in our study were most hbv serologically positive (312/413, 75.5%). |
| PubMedID- 23633957 | Rna sequencing (rna-seq) analysis of patient liver biopsies shows that viral triggering of these signaling pathways drives an inflammatory response linked with liver disease in patients with chronic hepatitis c. our results identify hcv-induced il-1β production by hepatic macrophages as a critical and central process that promotes liver inflammation and disease. |
| PubMedID- 26125137 | Low cross-neutralization of hepatitis c correlates with liver disease in immunocompromized patients. |
| PubMedID- 22318146 | hepatitis c virus (hcv) leads to progressive liver disease and hepatocellular carcinoma. |
| PubMedID- 21809486 | The purpose of this study was to determine the serum level of oxidized low-density lipoprotein (ox-ldl), and evaluate its association with different clinically valuable parameters of liver disease in patients with chronic hepatitis c. |
| PubMedID- 23311684 | Problem drug users are at high risk of liver disease resulting from hepatitis c virus (hcv) infection because of its high prevalence in this population 7. |
| PubMedID- 21294867 | The high proportion of patients with chronic liver disease associated with hepatitis c virus coinfection might have contributed to lessen the differences between treatment groups. |
| PubMedID- 22160684 | In a significant portion of patients chronic hepatitis c infection leads to serious liver diseases, including fibrosis, cirrhosis, and hepatocellular carcinoma. |
| PubMedID- 20517909 | Timing of hepatitis c antiviral therapy in patients with advanced liver disease: a decision analysis model. |
| PubMedID- 23874824 | Among the main causes of liver disease, co-infection with the hepatitis c (hcv) or hepatitis b (hbv) virus is the most frequent and has the worst prognosis 3. |
| PubMedID- 25737729 | However, there is no data supporting the association between periodontal disease and patients with liver diseases associated with hepatitis c virus (hcv) and/or hepatitis b virus (hbv) infection. |
| PubMedID- 23061403 | In high income settings, chronic liver disease – associated with hepatitis c and b virus, long term drug-induced toxicity, alcohol related and non-alcoholic fatty liver disease – has become a leading cause of chronic morbidity and mortality in people living with hiv . |
| PubMedID- 21911884 | Conclusion: based on our data, microsatellite variations in the hmox1 and ugt1a1 genes are not likely to protect from progression of liver disease in patients with chronic hepatitis c. |
Page: 1 2